CYRS-ONC7

N/A

Report date: 2025/06/11 11:23:37
NME

Base Information

Drug NameCYRS-ONC7
Drug Alias Nameantibody recruiting molecule (Cyrus Therapeutics)CYRS-ONC7ONC-7
ClassificationSmall molecules
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyrus Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A